GlobeNewswire 04-18 Zscaler Positioned as a Leader in the 2024 Gartner® Magic Quadrant™ for Security Service Edge (SSE) ...
GlobeNewswire 04-18 LYFT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lyft, Inc. Investors with Subs...
GlobeNewswire 04-15 One Stop Systems CEO and Chairman Issue Letter to Shareholders
GlobeNewswire 04-15 AGILON HEALTH, INC. (NYSE: AGL) DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Dead...
GlobeNewswire 04-15 Invivyd Receives Healthcare Common Procedure Coding System (HCPCS) Reimbursement Codes from the U.S....
GlobeNewswire 04-12 Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical ...
GlobeNewswire 04-12 Invivyd Announces CEO Transition
GlobeNewswire 04-11 LYFT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lyft, Inc. Investors with Subs...
GlobeNewswire 04-09 Kartoon Studios Reports Strong Progress and Provides Business Update for the Fourth Quarter and Full...
GlobeNewswire 04-09 Omega Therapeutics Presents New Preclinical Data at AACR 2024 Supporting the Potential of Precision ...
GlobeNewswire 04-04 Invivyd Provides PEMGARDA™ Launch Update and Announces 2024 Net Product Revenue Guidance in the Rang...
GlobeNewswire 04-04 New Survey Reveals Present-Day Risks of Asbestos Exposure in America - 38% in High-Risk Jobs, 47% Vu...
GlobeNewswire 04-04 LYFT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lyft, Inc. Investors with Subs...
GlobeNewswire 04-03 AGL INVESTOR ALERT: Robbins Geller Rudman & Dowd LLP Files Class Action Lawsuit Against agilon healt...
GlobeNewswire 04-02 Fractyl Health Expands Leadership with Appointment of Adrian Kimber as Chief Commercial Officer to S...
GlobeNewswire 04-01 IntelliTrans Placed in 2024 Magic Quadrant™ for Real-Time Transportation Visibility Platforms
GlobeNewswire 04-01 Fractyl Health Receives FDA IDE Approval for the Revita® Remain-1 Pivotal Study of Weight Maintenanc...
GlobeNewswire 03-28 Purple Biotech to Present New Data On its Oncology Drug NT219 at AACR 2024
GlobeNewswire 03-28 Invivyd Reports Full Year 2023 Financial Results and Recent Business Highlights
GlobeNewswire 03-28 LYFT INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Lyft, Inc. Investors with Subs...
GlobeNewswire 03-27 Odysight.ai Announces 2023 Financial Results and Provides Corporate Update
GlobeNewswire 03-27 Proofpoint Unleashes the Power of Behavioral AI to Thwart Data Loss over Email
GlobeNewswire 03-27 Endeavour Announces Completion of Investigation and Key Findings
GlobeNewswire 03-22 Invivyd Announces FDA Authorization for Emergency Use of PEMGARDA™ (Formerly VYD222) for Pre-exposu...
GlobeNewswire 03-21 Lyra Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate...